Chintagumpala, Murali M <br/><br/>
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group.  [electronic resource] 

 -  Journal of neuro-oncology  Apr 2006 
 - 193-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0167-594X 
<br/><br/><label>Standard No.: </label>10.1007/s11060-005-9024-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Adolescent<br/>Adult<br/>Alkyl and Aryl Transferases--metabolism<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Brain Neoplasms--drug therapy<br/>Carrier Proteins--metabolism<br/>Child<br/>Child, Preschool<br/>Disease-Free Survival<br/>Female<br/>Glioma--drug therapy<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>MutL Protein Homolog 1<br/>MutS Homolog 2 Protein--metabolism<br/>Neoplasm, Residual<br/>Nuclear Proteins--metabolism<br/>Procarbazine--administration & dosage<br/>Survival Analysis<br/>Topotecan--administration & dosage